Clinical Trial Failure

I don't think anyone at the Board has mentioned bieng part of this, but it is important to be aware of, especially members with T-cell issues.
max
http://www.foxnews.com/health/2016/07/08/juno-cancer-study-halted-after-patient-deaths.html
.
.
Comments
-
Strange demographic - 20
Strange demographic - 20 somethings, and a strange dynamic in the unpredicted and undesireable side effect. I had fludarabine and Cyclophosphamide as conditioning for my transplant (it is SOP at Fred Hutch) and nearly everyone I know maintains that I survived it. This is a huge blow to the trial, but the data, morbid as it is, will certainly help to guide future trials. However, going to a less effective conditioning regimen seems only to guarantee worse overall results. A true catch-22 and sadly, part and parcel of research.
0
Discussion Boards
- 119.2K All Discussion Boards
- 5 CSN Information
- 5 Welcome to CSN
- 119.3K Cancer specific
- 2.7K Anal Cancer
- 424 Bladder Cancer
- 297 Bone Cancers
- 1.6K Brain Cancer
- 28.1K Breast Cancer
- 377 Childhood Cancers
- 27.7K Colorectal Cancer
- 4.6K Esophageal Cancer
- 1.1K Gynecological Cancers (other than ovarian and uterine)
- 12.6K Head and Neck Cancer
- 6.2K Kidney Cancer
- 643 Leukemia
- 767 Liver Cancer
- 4K Lung Cancer
- 5K Lymphoma (Hodgkin and Non-Hodgkin)
- 217 Multiple Myeloma
- 7.1K Ovarian Cancer
- 35 Pancreatic Cancer
- 477 Peritoneal Cancer
- 5K Prostate Cancer
- 1.1K Rare and Other Cancers
- 521 Sarcoma
- 693 Skin Cancer
- 633 Stomach Cancer
- 190 Testicular Cancer
- 1.5K Thyroid Cancer
- 5.7K Uterine Cancer
- 6.2K Other Discussion Boards